A carregar...
Ziv-aflibercept in macular disease
BACKGROUND/AIMS: Aflibercept is an approved therapy for neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DME). In vitro and in vivo studies did not detect toxicity to the retinal pigment epithelium cells using the approved cancer protein, ziv-aflibercept. Our purpose i...
Na minha lista:
| Publicado no: | Br J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4518747/ https://ncbi.nlm.nih.gov/pubmed/25677668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-306319 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|